In vivo fluorescence imaging of conjunctival goblet cells.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 10 2019
29 10 2019
Historique:
received:
20
05
2019
accepted:
07
10
2019
entrez:
31
10
2019
pubmed:
31
10
2019
medline:
20
11
2020
Statut:
epublish
Résumé
Conjunctival goblet cells (GCs) are specialized epithelial cells that secrete mucins onto the ocular surface to maintain the wet environment. Assessment of GCs is important because various ocular surface diseases are associated with their loss. Although there are GC assessment methods available, the current methods are either invasive or difficult to use. In this report, we developed a simple and non-invasive GC assessment method based on fluorescence imaging. Moxifloxacin ophthalmic solution was used to label GCs via topical administration, and then various fluorescence microscopies could image GCs in high contrasts. Fluorescence imaging of GCs in the mouse conjunctiva was confirmed by both confocal reflection microscopy and histology with Periodic acid-Schiff (PAS) labeling. Real-time in-vivo conjunctival GC imaging was demonstrated in a rat model by using both confocal fluorescence microscopy and simple wide-field fluorescence microscopy. Different GC densities were observed in the forniceal and bulbar conjunctivas of the rat eye. Moxifloxacin based fluorescence imaging provides high-contrast images of conjunctival GCs non-invasively and could be useful for the study or diagnosis of GC related ocular surface diseases.
Identifiants
pubmed: 31664078
doi: 10.1038/s41598-019-51893-4
pii: 10.1038/s41598-019-51893-4
pmc: PMC6820527
doi:
Substances chimiques
Moxifloxacin
U188XYD42P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
15457Références
Clin Exp Optom. 2004 Nov;87(6):377-85
pubmed: 15575811
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1397-400
pubmed: 20185840
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):144-50
pubmed: 19696170
Ophthalmology. 1997 Feb;104(2):223-35
pubmed: 9052626
Ophthalmology. 1985 Jun;92(6):728-33
pubmed: 3897935
Ophthalmology. 1984 Jun;91(6):545-52
pubmed: 6462619
J Biophotonics. 2020 Jan;13(1):e201900197
pubmed: 31368257
Arch Ophthalmol. 1984 Jul;102(7):1049-51
pubmed: 6378156
Exp Eye Res. 2004 Mar;78(3):457-72
pubmed: 15106925
Sci Rep. 2018 Sep 21;8(1):14174
pubmed: 30242205
Toxicol In Vitro. 2016 Jun;33:54-62
pubmed: 26916085
Exp Eye Res. 1979 Sep;29(3):291-301
pubmed: 391581
Invest Ophthalmol. 1975 Apr;14(4):299-302
pubmed: 1123285
J Pharm Biomed Anal. 2005 Feb 23;37(2):327-32
pubmed: 15708674
Science. 1990 Apr 6;248(4951):73-6
pubmed: 2321027
Cont Lens Anterior Eye. 2016 Jun;39(3):221-6
pubmed: 26852166
Am J Physiol. 1992 Oct;263(4 Pt 1):L413-29
pubmed: 1415719
Sci Rep. 2018 Jun 20;8(1):9415
pubmed: 29925864
Cornea. 2006 Aug;25(7):781-8
pubmed: 17068454
Am J Optom Physiol Opt. 1974 Oct;51(10):765-9
pubmed: 4429120
Sci Rep. 2016 Jun 10;6:27142
pubmed: 27283889
Invest Ophthalmol Vis Sci. 1988 Jun;29(6):969-75
pubmed: 3372169